Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You sound more confident in approval. LOL. Your previous postings suggested you knew about something unscrupulous going down. What happened with that?
>>I think that the odds of MWBO being granted the MAA in 2024 is 0%.
How much time do you think Advent put into submitting the application to MHRA?
Posted this here a long time ago. If anyone is interested there's a lot to be learned from this document.
>>Believe Change is Desperately Needed to Peregrine's Board Given Current Strategy, Poor Corporate Governance, Apparent Misalignment of Interests with Stockholders and Constant Dilution
>>collectively the second largest stockholder of Peregrine Pharmaceuticals, Inc. ("Peregrine" or the "Company") (NASDAQ: PPHM), with aggregate beneficial ownership of approximately 8.8%
>>As explained in the letter, Ronin believes that there are opportunities to increase stockholder value; however, Ronin is concerned that stockholders will continue to suffer unless the Board is reconstituted with directors who will represent stockholders' best interests.
>>we were shocked that neither Steven W. King nor Paul J. Lytle, Peregrine's Chief Executive Officer and Chief Financial Officer, respectively, could articulate any long-term strategy for addressing the capital needs of the Company, curing the outstanding going concern notice or rectifying the Company's corporate governance shortcomings, including the apparent interest misalignment of directors and other problems associated with Peregrine's Board of Directors (the "Board").
https://www.prnewswire.com/news-releases/ronin-trading-and-sw-investment-management-issue-letter-to-stockholders-of-peregrine-pharmaceuticals-300487810.html
So how many more shares will you be buying today? LOL
Just more poorly thought out fantasy.
Sometimes companies, like people, make their own enemies.
Touché.
>>If the board truly believed in the crimes committed against the company and its shareholders they would delay awarding themselves shares until such time that the manipulation is dealt with through the courts or the company actually gains approval for DCVAX-L.
Here we go again. So you're saying Sawston is worth nothing?
>>the options granted are worth zero.
Wow! ...Great point. Wish I had thought of it. I've posted here many times about the ethics of knowingly allowing alleged spoofing to continue on for so long while the company was collecting retail. But I failed to think about management awarding themselves during said period.
>>You have to remember that the company has known about the manipulation occurring to their SP since 2015 yet they asked for an incredible amount of shares at the most depressed time for the SP.
"Dr. Bella". Hahahaha!!!
Careful what you say about "New chapters". Take note that nowhere in this nut's diatribe did he mention shareholder losses, fiduciary duty, or management performance for shareholder returns.
>>The Company used approximately $12.4 million of cash in its operating activities during the three months ended March 31, 2024.
The Company does not expect to generate material revenue in the near future from the sale of products
>>Our management determined that there was substantial doubt about our ability to continue as a going concern for at least one year after the annual consolidated financial statements were issued, and management’s concerns about our ability to continue as a going concern within the year following this report persist.
>>Related Party Accounts Payable
As of March 31, 2024, there were outstanding unpaid accounts payable and accrued expenses owed to Advent as summarized in the following table (in thousands). These unpaid amounts are part of the Related Party expenses reported in the above section.
Nope. Try harder. They could sell those shares right around this current price and still do well. Also those shares can be used for bargaining and could be repriced in a restructure.
>>then why ask for more shares because they won't be worth anything.
Rhoid also calls management "Incompetent buffoons " on an almost daily basis while still claiming to load up at every opportunity. He's also adamant about ignoring the skeptics. Just goes to show.
NWBO is a stone's throw away from either bankruptcy or a restructure. Should that occur you can toss your "equitable deal" out the window. Without any large non insider holders to represent retail common, Advent could have its pickings.
>>If at some point nwbo and Advent decide to go their separate ways, nwbo would either retain ownership of the Sawston facility and physical assets or negotiate equitable deal.
The disciples are so desperate to confuse poor retail that they're stealing the skeptics language without even caring it makes no sense to call someone who questions the company a "shill" or "boiler room" participant.
LOL. These disciples never quit. Either a total moron or another shill. So embarrassing.
Doc's reply so is so confusing I can't even reply to it but yours I'll try. Are you saying the CEO decided to personally own the $billion CDMO so NWBO shareholders wouldn't be burdened by a takeover?
>>One reason I can think of is for fending off unwanted takeover since Advent isn’t a public entity but I can’t say that is the primary reason or even a reason for sure, just conceivably.
It could double from 25 cents for a day or two with an MHRA approval in 2025 before settling back down.
After Les mentioned his 50,000 retail shareholders there's bound to be quite a summer shakeout coming.
The proxy company they're paying $90k to is mentioned in the filing. Did they have a pitch or just reading a script?
Do you think this is an exercise the newly independent MHRA wants to go through maybe just for learning / experience purposes?
They're using a court sketch artist this year.
Probably so. The Bigger thing is weird because he commented a month ago about AF but no more on NWBO. Also looks like he never mentions Rago anymore and Rago stopped commenting on X.
Poor Rhoid has everyone on ignore that can help him. LOL
What about Bigger? Oh wait, the disciples don't talk about him anymore.
LC was right too. How many Flops is that now for you?
2025 by the time it all gets ironed out, IMO, assuming the plug isn't pulled early, of course...
And, there's the next question for you:
If MHRA has no intention of approving L how long will they allow this to go on? And, if NICE has no intention of approving cost how long will they allow this to go on? ...Is no news actually good news in this case or just more time for extra breadcrumbs? Learn Flip, and please address this question in a realistic manner.
That's what happens when you ignore the skeptics here.
"Fooled us all again."
Yes, we all understand the arrangement but don't really have the details. My point was that NWBO has done little to promote their "CMO" in terms of name recognition. Even their own website barely mentions it.
With LP's success and experience with private Cognate (also a questionable move), I can think of no good reason the CDMO shouldn't have been placed under NWBO. Surely the banks would've loaned NWBO the cash.
These are all good questions for the ASM that'll never be asked, of course.
Notice how the disciples here are trained to avoid calling Sawston "Northwest Bio". Northwest Bio is reserved for Les' DC office. Instead it's referred to as "The facility" or soon perhaps "Advent's CMO" or just "Advent".
>>Manufacturing in the UK and jumpstarting Sawston as an advanced biotechnology hub is a major plus!
I suspect SIO is another breadcrumb to be used here and will go the way of Woodford, Bigger, that fracking guy, and the rest who ever touched this stock. SIO is a hedge fund so you know they've got a short position. Or they shorted up front to provide the $3.5.
It took eight years longer with no other trials being run and Direct shelved. A bad decision to change endpoint and use EC's rather than run a fresh new trial. "Bullet proof" is not a phrase I'd use. LOL.
JAMA is not without its controversy.
No rabbits out of hats should be required if DCVAX is the real deal. No buyers and no partners sums it up. We'll have to agree to disagree on Sawston. All I see is Advent doing all the winning. That $40M profit from the sale could've gone to a quality trial or your own CDMO and not hers.
There are other makers of units just like Eden. We'll see if it works and if favors shareholders or Advent more.
You didn't read the proxy material?
Always such a unique situation for LP and little NWBO. Eye rolls.
At this point most all journalist know about this crew and their history of employment and fake outs. I thought that's the reason shareholders were paying out all those options. LOL
And, no indication of any suitor or even partner based on the recent cash raise and this, among other things.
>>The Company does not currently have any arrangements that would trigger payments upon termination of a NEO or upon a change in control of the Company. However, the Company plans to enter into employment agreements with Ms. Powers, Mr. Goldman and Dr. Boynton in due course, which may contain such arrangements.
We've heard nothing in terms of RFI news so who knows where MHRA is in the process. My understanding from communications posted here is that NICE has not yet received NWBO's paperwork. NICE will need a year to determine the bottom line. For all we know MHRA could've placed the application to the side until NICE or whoever receives all the paperwork. That's the NWBO way.
Yeah, but based on history it'll go into 2025 before there's anything definitive, assuming the application is even being considered, of course.
Yes, please do!...All the way to the end including the chancellor's statements.
>>Read the Proxy please, please,
Four paragraphs of garbage. Please go back to your influencer blog and keep dreaming about being the next Roaring Kitty.
Now for a realty check.
-The trial went on unnecessarily long with nearly everyone passing on at some point.
-The FDA and EMA appear to want nothing to do with the trial.
-MHRA nod without a NICE nod will mean little. UK is notoriously frugal.
-The company continues to run on fumes unable to do a substantial deal to even run other trials.
-Sawston seems custom made for Advent even down to selling cryo services
-They sold shareholders fledgling CMO property to the Chinese and the CEO set up her own private CDMO to manage nearly all operations.
-Les does the Big Biz Show while the CEO CFO hasn't been seen doing a presentation in public for five years.
-Massive sneaky options grabs rivaling something a Boeing CEO would do.
-No employee contracts in place for the two leaders.
I could go on but won't. The only true accomplishment to date that benefits retail is the JAMA pub, IMO, and that is not without controversy.
I don't believe those companies are running on fumes with legacy shareholders down 99.x% of their investment.
>>and there are many CEOs making over $25 million a year.